RACHELLE FROST: Open Payments
NPI 1730105214 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 12 payments from 8 companies in 2025. Trend: 2023 $384 · 2024 $306 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: LEQVIO, UPTRAVI, ELIQUIS, JARDIANCE, FUROSCIX, REPATHA, INSPIRE, WINREVAIR.
Industry payments across UT — which companies pay providers there.
